Bod signs distribution agreement with Gold Coast cannabis group

Bod signs distribution agreement with Gold Coast cannabis group

Listed cannabis healthcare company Bod Australia (ASX: BDA) has teamed up with Burleigh Heads Cannabis (BHC) and partner company Cannabis Doctors Australia (CDA) on a distribution agreement.

Under the agreement Bod will gain access to BHC's wholesale network and will be able to utilise CDA's education, support and products for its network of patients and doctors seeking access to medicinal cannabis in Australia.

Specifically, the agreement will see Bod's MediCabilis product distributed and promoted around Australia.

CDA have a number of clinics and an established patient base in Australia. The group have successfully processed over 1,300 approvals since October 2018, resulting in more than 1,800 medicinal cannabis prescriptions.

The group recently closed a crowdfunding campaign to boost its growth both in Australia and New Zealand.

CDA hoped to raise $500,000 minimum but closed the crowdfunding round securing $1.5 million from 547 people via crowdfunding platform PledgeMe.

CDA was formed in October 2018 by Dr Matua Jansen (pictured right), a former hospital oncology specialist, and his cousin, medical director, Dr Ben Jansen (pictured left), who is currently a registered general practitioner and holds a fellowship in urgent care in Australia and New Zealand.

The educators and promoters of medicinal cannabis have commenced patient approvals for MediCabilis through its physical clinics and telehealth service. Bod anticipates strong demand for its product and hopes to see prescriptions increase over the coming months.

In addition to the distribution agreement, Bod and BHC intend to collaborate on novel non-THC cannabis prescription products to meet the needs of both physicians and patients.

"BHC and CDA are leaders in medicinal cannabis and have extensive networks of medicinal specialists, physicians and patients nationwide," says Bod Australia CEO Jo Patterson.

"This provides an excellent foundation for Bod to grow medicinal cannabis sales much more rapidly in Australia and New Zealand in the coming months."

"As well, Bod is in ongoing discussions with a number of potential distribution partners internationally to drive further revenue growth and looks forward to updating shareholders in the near term."

Shares in Bod are up 3.92 per cent to $0.26 per share at 11.43am AEST.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Advertisement

Related Stories

Logan edtech Go1 hits unicorn status as valuation exceeds $1 billion

Logan edtech Go1 hits unicorn status as valuation exceeds $1 billion

Logan, QLD-based education technology company Go1 has been on a r...

Lendlease, IKEA join forces to help QLD women and children escaping family and domestic violence

Lendlease, IKEA join forces to help QLD women and children escaping family and domestic violence

Amidst an acute shortage of housing options for women and childre...

New community case for Brisbane, QLD will open doors to all of Victoria

New community case for Brisbane, QLD will open doors to all of Victoria

A gentleman in his 60s who attended a Portuguese restaurant in Br...

Soul Patts, Milton Corp plan $10.6 billion merger

Soul Patts, Milton Corp plan $10.6 billion merger

Two Sydney-based investment houses with more than 230 years in op...